Cyclin Dependent Kinase Inhibitor Market, Global Outlook and Forecast 2022-2028

April 2022 | 62 pages | ID: CF0FD2BBD490EN
Market Monitor Global

Abstracts

Cyclin-dependent kinase inhibitor function as tumor suppressor proteins by inhibiting the enzyme cyclin-dependent kinase. The enzyme cyclin-dependent kinase controls cell cycle progression, transcription, mRNA processing, and differentiation. Cyclin-dependent kinase inhibitor arrest cell cycle at the G1 phase leading to mitosis. Cyclin-dependent kinase inhibitors are employed in the treatment of cancers by preventing over proliferation of cancer cells. Cyclin-dependent kinase are very active in most cancers which is rational to the use of cyclin-dependent kinase inhibitor as anti-cancer agents.

This report contains market size and forecasts of Cyclin Dependent Kinase Inhibitor in Global, including the following market information:

Global Cyclin Dependent Kinase Inhibitor Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cyclin Dependent Kinase Inhibitor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Broad CDK inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cyclin Dependent Kinase Inhibitor include Eli Lilly, Pfizer, Novartis, Astex Pharmaceuticals, Merck, Bio-Techne, Sanofi, Bayer and Syros Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cyclin Dependent Kinase Inhibitor companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cyclin Dependent Kinase Inhibitor Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cyclin Dependent Kinase Inhibitor Market Segment Percentages, by Type, 2021 (%)

• Broad CDK inhibitors
• Specific CDK inhibitors

Global Cyclin Dependent Kinase Inhibitor Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cyclin Dependent Kinase Inhibitor Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Cyclin Dependent Kinase Inhibitor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cyclin Dependent Kinase Inhibitor Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cyclin Dependent Kinase Inhibitor revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cyclin Dependent Kinase Inhibitor revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Eli Lilly
• Pfizer
• Novartis
• Astex Pharmaceuticals
• Merck
• Bio-Techne
• Sanofi
• Bayer
• Syros Pharmaceuticals
• Amgen
• BioCAD
• Otsuka Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cyclin Dependent Kinase Inhibitor Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cyclin Dependent Kinase Inhibitor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CYCLIN DEPENDENT KINASE INHIBITOR OVERALL MARKET SIZE

2.1 Global Cyclin Dependent Kinase Inhibitor Market Size: 2021 VS 2028
2.2 Global Cyclin Dependent Kinase Inhibitor Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cyclin Dependent Kinase Inhibitor Players in Global Market
3.2 Top Global Cyclin Dependent Kinase Inhibitor Companies Ranked by Revenue
3.3 Global Cyclin Dependent Kinase Inhibitor Revenue by Companies
3.4 Top 3 and Top 5 Cyclin Dependent Kinase Inhibitor Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cyclin Dependent Kinase Inhibitor Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cyclin Dependent Kinase Inhibitor Players in Global Market
  3.6.1 List of Global Tier 1 Cyclin Dependent Kinase Inhibitor Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cyclin Dependent Kinase Inhibitor Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cyclin Dependent Kinase Inhibitor Market Size Markets, 2021 & 2028
  4.1.2 Broad CDK inhibitors
  4.1.3 Specific CDK inhibitors
4.2 By Type - Global Cyclin Dependent Kinase Inhibitor Revenue & Forecasts
  4.2.1 By Type - Global Cyclin Dependent Kinase Inhibitor Revenue, 2017-2022
  4.2.2 By Type - Global Cyclin Dependent Kinase Inhibitor Revenue, 2023-2028
  4.2.3 By Type - Global Cyclin Dependent Kinase Inhibitor Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cyclin Dependent Kinase Inhibitor Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Cyclin Dependent Kinase Inhibitor Revenue & Forecasts
  5.2.1 By Application - Global Cyclin Dependent Kinase Inhibitor Revenue, 2017-2022
  5.2.2 By Application - Global Cyclin Dependent Kinase Inhibitor Revenue, 2023-2028
  5.2.3 By Application - Global Cyclin Dependent Kinase Inhibitor Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cyclin Dependent Kinase Inhibitor Market Size, 2021 & 2028
6.2 By Region - Global Cyclin Dependent Kinase Inhibitor Revenue & Forecasts
  6.2.1 By Region - Global Cyclin Dependent Kinase Inhibitor Revenue, 2017-2022
  6.2.2 By Region - Global Cyclin Dependent Kinase Inhibitor Revenue, 2023-2028
  6.2.3 By Region - Global Cyclin Dependent Kinase Inhibitor Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cyclin Dependent Kinase Inhibitor Revenue, 2017-2028
  6.3.2 US Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
  6.3.3 Canada Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
  6.3.4 Mexico Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cyclin Dependent Kinase Inhibitor Revenue, 2017-2028
  6.4.2 Germany Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
  6.4.3 France Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
  6.4.4 U.K. Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
  6.4.5 Italy Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
  6.4.6 Russia Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
  6.4.7 Nordic Countries Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
  6.4.8 Benelux Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cyclin Dependent Kinase Inhibitor Revenue, 2017-2028
  6.5.2 China Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
  6.5.3 Japan Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
  6.5.4 South Korea Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
  6.5.5 Southeast Asia Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
  6.5.6 India Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cyclin Dependent Kinase Inhibitor Revenue, 2017-2028
  6.6.2 Brazil Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
  6.6.3 Argentina Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cyclin Dependent Kinase Inhibitor Revenue, 2017-2028
  6.7.2 Turkey Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
  6.7.3 Israel Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
  6.7.4 Saudi Arabia Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028
  6.7.5 UAE Cyclin Dependent Kinase Inhibitor Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Eli Lilly
  7.1.1 Eli Lilly Corporate Summary
  7.1.2 Eli Lilly Business Overview
  7.1.3 Eli Lilly Cyclin Dependent Kinase Inhibitor Major Product Offerings
  7.1.4 Eli Lilly Cyclin Dependent Kinase Inhibitor Revenue in Global Market (2017-2022)
  7.1.5 Eli Lilly Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Cyclin Dependent Kinase Inhibitor Major Product Offerings
  7.2.4 Pfizer Cyclin Dependent Kinase Inhibitor Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Cyclin Dependent Kinase Inhibitor Major Product Offerings
  7.3.4 Novartis Cyclin Dependent Kinase Inhibitor Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Astex Pharmaceuticals
  7.4.1 Astex Pharmaceuticals Corporate Summary
  7.4.2 Astex Pharmaceuticals Business Overview
  7.4.3 Astex Pharmaceuticals Cyclin Dependent Kinase Inhibitor Major Product Offerings
  7.4.4 Astex Pharmaceuticals Cyclin Dependent Kinase Inhibitor Revenue in Global Market (2017-2022)
  7.4.5 Astex Pharmaceuticals Key News
7.5 Merck
  7.5.1 Merck Corporate Summary
  7.5.2 Merck Business Overview
  7.5.3 Merck Cyclin Dependent Kinase Inhibitor Major Product Offerings
  7.5.4 Merck Cyclin Dependent Kinase Inhibitor Revenue in Global Market (2017-2022)
  7.5.5 Merck Key News
7.6 Bio-Techne
  7.6.1 Bio-Techne Corporate Summary
  7.6.2 Bio-Techne Business Overview
  7.6.3 Bio-Techne Cyclin Dependent Kinase Inhibitor Major Product Offerings
  7.6.4 Bio-Techne Cyclin Dependent Kinase Inhibitor Revenue in Global Market (2017-2022)
  7.6.5 Bio-Techne Key News
7.7 Sanofi
  7.7.1 Sanofi Corporate Summary
  7.7.2 Sanofi Business Overview
  7.7.3 Sanofi Cyclin Dependent Kinase Inhibitor Major Product Offerings
  7.7.4 Sanofi Cyclin Dependent Kinase Inhibitor Revenue in Global Market (2017-2022)
  7.7.5 Sanofi Key News
7.8 Bayer
  7.8.1 Bayer Corporate Summary
  7.8.2 Bayer Business Overview
  7.8.3 Bayer Cyclin Dependent Kinase Inhibitor Major Product Offerings
  7.8.4 Bayer Cyclin Dependent Kinase Inhibitor Revenue in Global Market (2017-2022)
  7.8.5 Bayer Key News
7.9 Syros Pharmaceuticals
  7.9.1 Syros Pharmaceuticals Corporate Summary
  7.9.2 Syros Pharmaceuticals Business Overview
  7.9.3 Syros Pharmaceuticals Cyclin Dependent Kinase Inhibitor Major Product Offerings
  7.9.4 Syros Pharmaceuticals Cyclin Dependent Kinase Inhibitor Revenue in Global Market (2017-2022)
  7.9.5 Syros Pharmaceuticals Key News
7.10 Amgen
  7.10.1 Amgen Corporate Summary
  7.10.2 Amgen Business Overview
  7.10.3 Amgen Cyclin Dependent Kinase Inhibitor Major Product Offerings
  7.10.4 Amgen Cyclin Dependent Kinase Inhibitor Revenue in Global Market (2017-2022)
  7.10.5 Amgen Key News
7.11 BioCAD
  7.11.1 BioCAD Corporate Summary
  7.11.2 BioCAD Business Overview
  7.11.3 BioCAD Cyclin Dependent Kinase Inhibitor Major Product Offerings
  7.11.4 BioCAD Cyclin Dependent Kinase Inhibitor Revenue in Global Market (2017-2022)
  7.11.5 BioCAD Key News
7.12 Otsuka Pharmaceutical
  7.12.1 Otsuka Pharmaceutical Corporate Summary
  7.12.2 Otsuka Pharmaceutical Business Overview
  7.12.3 Otsuka Pharmaceutical Cyclin Dependent Kinase Inhibitor Major Product Offerings
  7.12.4 Otsuka Pharmaceutical Cyclin Dependent Kinase Inhibitor Revenue in Global Market (2017-2022)
  7.12.5 Otsuka Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cyclin Dependent Kinase Inhibitor Market Opportunities & Trends in Global Market
Table 2. Cyclin Dependent Kinase Inhibitor Market Drivers in Global Market
Table 3. Cyclin Dependent Kinase Inhibitor Market Restraints in Global Market
Table 4. Key Players of Cyclin Dependent Kinase Inhibitor in Global Market
Table 5. Top Cyclin Dependent Kinase Inhibitor Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cyclin Dependent Kinase Inhibitor Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cyclin Dependent Kinase Inhibitor Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cyclin Dependent Kinase Inhibitor Product Type
Table 9. List of Global Tier 1 Cyclin Dependent Kinase Inhibitor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cyclin Dependent Kinase Inhibitor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cyclin Dependent Kinase Inhibitor Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cyclin Dependent Kinase Inhibitor Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cyclin Dependent Kinase Inhibitor Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cyclin Dependent Kinase Inhibitor Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cyclin Dependent Kinase Inhibitor Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cyclin Dependent Kinase Inhibitor Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2023-2028
Table 30. Eli Lilly Corporate Summary
Table 31. Eli Lilly Cyclin Dependent Kinase Inhibitor Product Offerings
Table 32. Eli Lilly Cyclin Dependent Kinase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Cyclin Dependent Kinase Inhibitor Product Offerings
Table 35. Pfizer Cyclin Dependent Kinase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Cyclin Dependent Kinase Inhibitor Product Offerings
Table 38. Novartis Cyclin Dependent Kinase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 39. Astex Pharmaceuticals Corporate Summary
Table 40. Astex Pharmaceuticals Cyclin Dependent Kinase Inhibitor Product Offerings
Table 41. Astex Pharmaceuticals Cyclin Dependent Kinase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 42. Merck Corporate Summary
Table 43. Merck Cyclin Dependent Kinase Inhibitor Product Offerings
Table 44. Merck Cyclin Dependent Kinase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 45. Bio-Techne Corporate Summary
Table 46. Bio-Techne Cyclin Dependent Kinase Inhibitor Product Offerings
Table 47. Bio-Techne Cyclin Dependent Kinase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Cyclin Dependent Kinase Inhibitor Product Offerings
Table 50. Sanofi Cyclin Dependent Kinase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 51. Bayer Corporate Summary
Table 52. Bayer Cyclin Dependent Kinase Inhibitor Product Offerings
Table 53. Bayer Cyclin Dependent Kinase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 54. Syros Pharmaceuticals Corporate Summary
Table 55. Syros Pharmaceuticals Cyclin Dependent Kinase Inhibitor Product Offerings
Table 56. Syros Pharmaceuticals Cyclin Dependent Kinase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 57. Amgen Corporate Summary
Table 58. Amgen Cyclin Dependent Kinase Inhibitor Product Offerings
Table 59. Amgen Cyclin Dependent Kinase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 60. BioCAD Corporate Summary
Table 61. BioCAD Cyclin Dependent Kinase Inhibitor Product Offerings
Table 62. BioCAD Cyclin Dependent Kinase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 63. Otsuka Pharmaceutical Corporate Summary
Table 64. Otsuka Pharmaceutical Cyclin Dependent Kinase Inhibitor Product Offerings
Table 65. Otsuka Pharmaceutical Cyclin Dependent Kinase Inhibitor Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cyclin Dependent Kinase Inhibitor Segment by Type in 2021
Figure 2. Cyclin Dependent Kinase Inhibitor Segment by Application in 2021
Figure 3. Global Cyclin Dependent Kinase Inhibitor Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cyclin Dependent Kinase Inhibitor Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cyclin Dependent Kinase Inhibitor Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cyclin Dependent Kinase Inhibitor Revenue in 2021
Figure 8. By Type - Global Cyclin Dependent Kinase Inhibitor Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cyclin Dependent Kinase Inhibitor Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cyclin Dependent Kinase Inhibitor Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cyclin Dependent Kinase Inhibitor Revenue Market Share, 2017-2028
Figure 12. US Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cyclin Dependent Kinase Inhibitor Revenue Market Share, 2017-2028
Figure 16. Germany Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 17. France Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cyclin Dependent Kinase Inhibitor Revenue Market Share, 2017-2028
Figure 24. China Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 28. India Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cyclin Dependent Kinase Inhibitor Revenue Market Share, 2017-2028
Figure 30. Brazil Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cyclin Dependent Kinase Inhibitor Revenue Market Share, 2017-2028
Figure 33. Turkey Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cyclin Dependent Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 37. Eli Lilly Cyclin Dependent Kinase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Cyclin Dependent Kinase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Cyclin Dependent Kinase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Astex Pharmaceuticals Cyclin Dependent Kinase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Cyclin Dependent Kinase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bio-Techne Cyclin Dependent Kinase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi Cyclin Dependent Kinase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bayer Cyclin Dependent Kinase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Syros Pharmaceuticals Cyclin Dependent Kinase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Amgen Cyclin Dependent Kinase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. BioCAD Cyclin Dependent Kinase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Otsuka Pharmaceutical Cyclin Dependent Kinase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)